Research Article
An Industrial Approach to Production of Tofacitinib Citrate (TFC) as an Anti-COVID-19 Agent: A Joint Experimental and Theoretical Study
Table 1
A comparison between the examples of the previous reports and the present work.
| Entry | Catalyst | Solvent | Temperature (°C) | Time (h) | Yield (%) | Type of workup | Ref |
| 1 | EDC/HOBT | DCM | R.T | 12 | 80 | Precipitation | [20] | 2 | TEA | Toluene | 100 | 24 | 65.3 | Extraction | [21] | 3 | TEA | DCM | −5 | 3.5 | 67.3 | Extraction | [21] | 4 | DBU | n-butanol | 40 | 18 | 87.6 | Precipitation | [22, 23] | 5 | DBU | n-butanol | 45 | Not stated | 85 | Precipitation | [24] | 6 | DBU | n-butanol | 40 | 20 | 93 | Precipitation | [25] | 7 | DBU | Ethanol | R.T | 6 | 50 | Precipitation | [26] | 8 | HOBT | DCM | R.T | 12 | 70 | Extraction | [27] | 9 | DBU | ACN | 40 | 6 | 72 | Precipitation | [28] | 10 | DBU | — | R.T | 11 | 95.1 | Precipitation | This work |
|
|